Combination Adjuvants Enhance Recombinant Protein Vaccine Protection against Fungal Infection

Authors:

Abstract
Fungal disease remains a challenging clinical and public health problem. Despite medical advances, invasive fungal infections have skyrocketed over the last decade and pose a mounting health threat in immunocompetent and -deficient hosts, with worldwide mortality rates ranking 7th, even ahead of tuberculosis.
All Related Versions
Funding Information
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (AI093553)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (AI035681, AI040996)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201800044C, HHS-N272201400053C, HHS-N272200800039C, U01-AI061142)

This publication has 27 references indexed in Scilit: